$55.66
-0.51-0.91%
Last update: Jun 11, 3:36 PM
BioMarin Pharmaceutical Inc Earnings Estimates
BMRNNASDAQ
BioMarin Pharmaceutical Earnings Estimates, EPS & Revenue | NASDAQ:BMRN
BioMarin Pharmaceutical (BMRN) is scheduled to report Q2 earnings on August 3, 2026. Analysts estimate EPS of $0.92 and quarterly revenue of $931.52M.
In the most recent quarter (Q1), BioMarin Pharmaceutical reported EPS of $0.76, missing estimates of $0.89 by 0.15%. Revenue came in at $766.21M, exceeding the estimate of $754.59M by 0.02%.
Over the last 4 quarters, BioMarin Pharmaceutical has averaged an EPS surprise of 0.43% and a revenue surprise of 0.04%.
Earnings Date
Aug 3
EPS Estimate
$0.920
Quarterly Revenue Estimate
$931.52M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$3.24B
BioMarin Pharmaceutical Earnings History
Analyze the earnings history of BioMarin Pharmaceutical using advanced sorting and filters.
Loading calendar...
BioMarin Pharmaceutical (BMRN) Earnings Per Share
The chart below shows BioMarin Pharmaceutical's reported EPS compared to analyst estimates over recent quarters.
BioMarin Pharmaceutical (BMRN) Revenue
The chart below shows BioMarin Pharmaceutical's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is BioMarin Pharmaceutical (NASDAQ:BMRN) reporting earnings?
BioMarin Pharmaceutical (BMRN) is scheduled to report earnings on August 3, 2026. The last reported earnings were for reported on May 4, 2026 for Q1.
What were the latest earnings per share (EPS) for BioMarin Pharmaceutical (NASDAQ:BMRN)?
The Actual EPS was $0.76, which missed the estimate of $0.89.
What were BioMarin Pharmaceutical’s (NASDAQ:BMRN) revenues?
The Actual Revenue was $766.21M, which beat the estimate of $754.59M.
